Holen Sie sich die Stockscreener-App
4.90
1.01%
-0.05
Handel nachbörslich:
4.95
0.05
+1.02%
Champions Oncology Inc Aktie (CSBR) Neueste Nachrichten
Champions Oncology Inc (2I3.MU) cash flow - au.finance.yahoo.com
Is Champions Oncology (NASDAQ:CSBR) Stock Worth Watching Today? - Kalkine Media
Champions Oncology Q4FY26 Results: Revenue up 12% to $59.4 million - scanx.trade
Full Transcript: Champions Oncology Q4 2026 Earnings Call - Benzinga
Champions Oncology, Inc.Common Stock (Nasdaq:CSBR) Price Chart - The Chronicle-Journal
CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth - Eastern Progress
Champions Oncology Inc (CSBR) (Q1 2027) Earnings Call Highlights: Data Licensing Surge and ... - Yahoo Finance
Champions Oncology Narrows Q1 Loss to $426,000 - Minichart
CHAMPIONS ONCOLOGY, INC. 1Q 2027: Revenue $15.23M, EPS $(0.03) — 10-Q Summary - TradingView
CSBR 10-Q FilingsChampions Oncology, Inc. SEC 10-Q - stocktitan.net
Champions Oncology Q4 Results: Adjusted EPS beats estimates - scanx.trade
Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript - The Globe and Mail
Champions Oncology, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
CSBR|Champions Oncology Inc|Price:5.096|Chg%:+0.086 - TradingKey
Champions Oncology posts 8.8% revenue growth an... - Pluang
Champions Oncology Fiscal Q1 2027 Earnings: Margin Expansion Lifts Adjusted EBITDA - TradingKey
Earnings call transcript: Champions Oncology tops Q1 2027 estimates, shares slip - Investing.com Nigeria
Champions Oncology Q1 Results: Adj. EPS up 400% to $0.05 - scanx.trade
Champions Oncology (CSBR) Q1 Fiscal 2027 Earnings Call: Revenue Up 9%, Services Margin Reaches 51% - TradingKey
Champions Oncology Q1 Earnings Call Highlights - Yahoo Finance
Champions Oncology earnings beat by $0.06, revenue topped estimates - Investing.com
Champions Oncology reports Q1 revenue $15.2M, adjusted EBITDA $0.7M and oncology services margin 51% - TradingView
CSBR: Revenue up 8.8% to $15.2M, oncology margin at 51%, adjusted EBITDA $671K, net loss $426K - TradingView
Champions Oncology posts better-than-expected Q1, but shares edge lower on higher costs - Investing.com
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2026 - marketscreener.com
CHAMPIONS ONCOLOGY ($CSBR) Releases Q1 2027 Earnings - Quiver Quantitative
Champions Oncology Reports Revenue of $15.2 Million - ACCESS Newswire
Oracle, Adobe, Copart and more set to report earnings Thursday By Investing.com - Investing.com Australia
Oracle, Adobe, Copart and more set to report earnings Thursday - Investing.com
CSBR Q1'26 Earnings: EPS estimate is (0.01) USD - TradingView
Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026 - Black Hills Pioneer
Champions Oncology Inc. (CSBR) Key Financial Ratios – Valuation, Profitability & More - Value Research
CSBR - Finviz
Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging - New Castle News
New imaging follows cancer treatments inside tumors—and links uptake to response - Stock Titan
Champions Oncology adds in-house SPECT/CT imaging to radiopharma platform - scanx.trade
Champions Oncology Inc. (CSBR) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Champions Oncology Inc. (CSBR) Peer Comparison – Compare with Others - Value Research
Anixa Biosciences Inc. (ANIX) Peer Comparison – Compare with Others - Value Research
Champions Oncology Inc (NASDAQ: CSBR) Share Price, CSBR Stock News, CSBR Share Price & Updates - kalkine.ca
Champions (CSBR) Range: Finishes 4.86% Up at $5.18 in the Latest Session; Price Setup: the Near-Term Reference Band Stretches From $4.92 to $5.44 in the Available RecordHidden Order - vinanet.vn
North-America Humanized Mouse and Rat Model Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
Japan Humanized Mouse and Rat Model Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
Rest-Of-Asia-Pacific Humanized Mouse and Rat Model Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
Latin-America Humanized Mouse and Rat Model Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
Comedian Michael Kosta Headlines Karmanos Comedy Champions on New October Date, Hosted by 101 WRIF's Jade Springart - PR Newswire
Precision Trading with Champions Oncology Inc. (CSBR) Risk Zones - Stock Traders Daily
OSTX Stock Price and Chart — AMEX:OSTX - TradingView
Manulife China Bank Life Champions Early Health Action and Financial Planning at The Art of Longevity - Mindanao Times
Residential Social Vulnerability Associated With Worse Survival Among Black Women With Epithelial Ovarian Cancer - The ASCO Post
China Patient Derived Xenografts/PDX Models Market Size, Share,Trends, Growth Analysis Report, 2030 - MarketsandMarkets
KLRS Stock Price and Chart — NASDAQ:KLRS - TradingView
NMAD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CSBR Q2 2026 Earnings: Narrower-Than-Expected Loss Still Leaves Investors Unimpressed as Shares Fall 3.66% - careplusvn.com
Technical Reactions to CSBR Trends in Macro Strategies - Stock Traders Daily
Champions Oncology Inc (CSBR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Champions Oncology (NASDAQ:CSBR) Stock Price Crosses Below 200 Day Moving AverageHere's Why - MarketBeat
Champions Oncology (CSBR) Pulls Back 2.7% as Shares Test Support Near $5.33Double EMA - dars.gov.et
Kingdom Of Saudi Arabia Patient Derived Xenografts/PDX Models Market (2025-2030) - MarketsandMarkets
Champions Oncology, Inc. Revenue Breakdown – NASDAQ:CSBR - TradingView
CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push - theglobeandmail.com
Champions Oncology Inc (CSBR) (Q4 2026) Earnings Call Highlights: Record Revenue and Positive ... - Yahoo Finance
AgomAb Therapeutics (AGMB) Holds Steady Near Resistance as Biotech Sector Shows Mixed SentimentHead and Shoulders - vinanet.vn
Champions Oncology Inc (CSBR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Champions Oncology Inc (CSBR) Institutional Confidence - TradingKey
3.06%
2.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):